dipak+sarkar - Available Technologies | Rutgers University Innovation Ventures

Search Results - dipak+sarkar

1 Results Sort By:
Combined Opioidergic and Beta-Adrenergic Drugs for Cancer and Immune Diseases
­â€‹ Figure 1. (Left) Combined, synergistic treatment with naltrexone (NTX), propranolol (PRO), and Anti-PD1 antibody shows decrease in tumor size, by volume. (Right) Combined treatment of NTX, DPDPE, and PRO similarly decreases tumor size compared to controls. Invention Summary: One of the major cancer therapy approaches that is being...
Published: 5/8/2024   |   Inventor(s): Dipak Sarkar
Keywords(s): Anti-cancer, Small molecules
Category(s): Technology Classifications > Cancer, Technology Classifications > Healthcare & Life Sciences